Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine

Adeline Nukuna1, Howard E Gendelman, Jenae Limoges

  • 1Center for Neurovirology and Neurodegenerative Disorders, Omahan NE 68195-5215, USA.

Journal of Neurovirology
|February 26, 2004
PubMed

Insights

Neuroinflammation in HIV-1-associated neurological disease is driven by productive viral infection in activated macrophages. This leads to overproduction of inflammatory factors and neurotoxins, causing neuronal dysfunction.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Controversies exist regarding neuroinvasive strains and viral replication necessity for neuro-AIDS progression.
  • Understanding the role of infected macrophages in HIV-1 neurological disease is crucial.

Purpose of the Study:

  • To investigate the role of specific viral strains and brain viral replication in disease progression.
  • To determine the impact of infected macrophages on neuropathology and neuronal function.

Main Methods:

  • Injected human monocyte-derived macrophages (MDMs) infected with diverse HIV-1 strains into SCID mice brains (caudate and putamen).
  • Assessed immunological activation, inflammatory reactions, and neuropathologic changes, including microglial reactions.

Main Results:

  • Infected MDMs induced significant inflammatory reactions and neuropathologic changes, irrespective of viral strain.
  • The intensity of neuropathology correlated with viral infection levels and the number of infected MDMs.
  • Activated macrophages overproduced proinflammatory factors and neurotoxins.

Conclusions:

  • HIV-1-associated neurological disease is linked to the level of productive viral infection in activated macrophages.
  • Virus infection in macrophages may impair immune responses, leading to neurotoxicity and neuronal dysfunction.